These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 8449952

  • 1. Identification of a major binding site for complement C3 on the IgG1 heavy chain.
    Shohet JM, Pemberton P, Carroll MC.
    J Biol Chem; 1993 Mar 15; 268(8):5866-71. PubMed ID: 8449952
    [Abstract] [Full Text] [Related]

  • 2. Serine 132 is the C3 covalent attachment point on the CH1 domain of human IgG1.
    Vidarte L, Pastor C, Mas S, Blázquez AB, de los Rios V, Guerrero R, Vivanco F.
    J Biol Chem; 2001 Oct 12; 276(41):38217-23. PubMed ID: 11447230
    [Abstract] [Full Text] [Related]

  • 3. Localization of the human complement component C3 binding site on the IgG heavy chain.
    Shohet JM, Bergamaschini L, Davis AE, Carroll MC.
    J Biol Chem; 1991 Oct 05; 266(28):18520-4. PubMed ID: 1917974
    [Abstract] [Full Text] [Related]

  • 4. Covalent attachment of human complement C3 to IgG. Identification of the amino acid residue involved in ester linkage formation.
    Sahu A, Pangburn MK.
    J Biol Chem; 1994 Nov 18; 269(46):28997-9002. PubMed ID: 7961863
    [Abstract] [Full Text] [Related]

  • 5. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates.
    Antón LC, Ruiz S, Barrio E, Marqués G, Sánchez A, Vivanco F.
    Eur J Immunol; 1994 Mar 18; 24(3):599-604. PubMed ID: 8125130
    [Abstract] [Full Text] [Related]

  • 6. C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway.
    Antón LC, Alcolea JM, Sánchez-Corral P, Marqués G, Sánchez A, Vivanco F.
    Biochem J; 1989 Feb 01; 257(3):831-8. PubMed ID: 2784671
    [Abstract] [Full Text] [Related]

  • 7. The covalent interaction of C3 with IgG immune complexes.
    Vivanco F, Muñoz E, Vidarte L, Pastor C.
    Mol Immunol; 1999 Feb 01; 36(13-14):843-52. PubMed ID: 10698338
    [Abstract] [Full Text] [Related]

  • 8. The C(H)1 domain of IgG is not essential for C3 covalent binding: importance of the other constant domains as targets for C3.
    Muñoz E, Vidarte L, Casado MT, Pastor C, Vivanco F.
    Int Immunol; 1998 Feb 01; 10(2):97-106. PubMed ID: 9580208
    [Abstract] [Full Text] [Related]

  • 9. Identification of the C3b receptor-binding domain in third component of complement.
    Becherer JD, Lambris JD.
    J Biol Chem; 1988 Oct 05; 263(28):14586-91. PubMed ID: 2971659
    [Abstract] [Full Text] [Related]

  • 10. A small domain (6.5 kDa) of bacterial protein G inhibits C3 covalent binding to the Fc region of IgG immune complexes.
    Muñoz E, Vidarte L, Pastor C, Casado M, Vivanco F.
    Eur J Immunol; 1998 Aug 05; 28(8):2591-7. PubMed ID: 9710236
    [Abstract] [Full Text] [Related]

  • 11. Lysine 322 in the human IgG3 C(H)2 domain is crucial for antibody dependent complement activation.
    Thommesen JE, Michaelsen TE, Løset GÅ, Sandlie I, Brekke OH.
    Mol Immunol; 2000 Nov 05; 37(16):995-1004. PubMed ID: 11395138
    [Abstract] [Full Text] [Related]

  • 12. Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates.
    Takata Y, Tamura N, Fujita T.
    J Immunol; 1984 May 05; 132(5):2531-7. PubMed ID: 6232320
    [Abstract] [Full Text] [Related]

  • 13. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.
    Gadd KJ, Reid KB.
    Biochem J; 1981 May 01; 195(2):471-80. PubMed ID: 7316962
    [Abstract] [Full Text] [Related]

  • 14. Identification of the C3b binding site in a recombinant vWF-A domain of complement factor B by surface-enhanced laser desorption-ionisation affinity mass spectrometry and homology modelling: implications for the activity of factor B.
    Hinshelwood J, Spencer DI, Edwards YJ, Perkins SJ.
    J Mol Biol; 1999 Nov 26; 294(2):587-99. PubMed ID: 10610782
    [Abstract] [Full Text] [Related]

  • 15. C3b2-IgG complexes retain dimeric C3 fragments at all levels of inactivation.
    Jelezarova E, Luginbuehl A, Lutz HU.
    J Biol Chem; 2003 Dec 19; 278(51):51806-12. PubMed ID: 14527961
    [Abstract] [Full Text] [Related]

  • 16. Formation of covalently linked C3-C3 dimers on IgG immune aggregates.
    Barrio E, Antón LC, Marqués G, Sánchez A, Vivanco F.
    Eur J Immunol; 1991 Feb 19; 21(2):343-9. PubMed ID: 1999223
    [Abstract] [Full Text] [Related]

  • 17. Covalent binding of C3b to monoclonal antibodies selectively up-regulates heavy chain epitope recognition by T cells.
    Santoro L, Drouet C, Reboul A, Mach JP, Colomb MG.
    Eur J Immunol; 1994 Jul 19; 24(7):1620-6. PubMed ID: 8026522
    [Abstract] [Full Text] [Related]

  • 18. Tyrosine is a potential site for covalent attachment of activated complement component C3.
    Sahu A, Pangburn MK.
    Mol Immunol; 1995 Jul 19; 32(10):711-6. PubMed ID: 7659097
    [Abstract] [Full Text] [Related]

  • 19. Isolation and characterization of the third complement component of axolotl (Ambystoma mexicanum).
    Avila D, Lambris JD.
    Comp Biochem Physiol B; 1990 Jul 19; 95(4):839-45. PubMed ID: 2344737
    [Abstract] [Full Text] [Related]

  • 20. Sequence of ovine Ig gamma 2 constant region heavy chain cDNA and molecular modelling of ruminant IgG isotypes.
    Clarkson CA, Beale D, Coadwell JW, Symons DB.
    Mol Immunol; 1993 Sep 19; 30(13):1195-204. PubMed ID: 8413324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.